Download - Novartis india
Novartis has been in India since 1947.
The Group operates in India through four entities
namely Novartis India Limited, Novartis Healthcare
Private Limited, Sandoz Private Limited and Chiron-
Behring Vaccine Private Limited.
In India Novartis has a presence in pharmaceuticals,
generics (pharmaceutical products that are off patent),
Vaccines, OTC (over-the-counter medicines), eye care.
Mission :- Want to discover , develop, and
successfully market innovative products to prevent
and cure disease , to ease suffering and to enhance
quality of life
Vision :- Want to provide share holder return that
reflect outstanding performance and to adequately
reward those who invest their money, time and
idea in our company.
Novartis Institute for Biomedical Research
NIBR is the global research organization of
Novartis. With more than 6000 scientists and
physicians around the world, NIBR is focused on
discovering new drugs that can change the practice
of medicine.
Increase in R&D spending from US $ 80 million in
2001 to 2.4 billion in 2013.
R&D efforts are guided by two principles:
Do we understand the underlying mechanism
or cause of the disease?
Does this disease represent a significant unmet
medical need in patients?
Novartis is well known for innovation
Novartis has a long-established track record of leadership inpharmaceutical research.
Also leverage this core R&D competence across otherdivisions, sharing research findings and knowledgethroughout organization.
Sandoz, the generics division of Novartis, is the worldleader in biosimilars, oncology injectables, dermatology,ophthalmics, and anti-infectives that have lost patentprotection.
By 2018, patents are scheduled to expire on biologics withglobal sales of more than USD 100 billion and Sandoz iswell-positioned to take full advantage of that opportunity.
Flu and the emerging meningococcal franchise will be keygrowth drivers for the Vaccines Division. The division alsohas a broad pipeline of new vaccines under development.
VACCINES :-
The Novartis influenza vaccines business is among
the world’s largest producers of influenza vaccines
Flucelvax ,Flaud ,Fluvirin
Rabipur from Novartis india contain Vaccines
Rabies
Used in animal bites
Sandoz (Generics)
Sandoz, the generic pharmaceuticals division
of Novartis, is a global industry leader, offering
affordable, high-quality medicines. It is the
third-largest division of Novartis, representing
nearly 16% of the Group’s total net sales.
OTC PRODUCT OF NOVARTIS
Focus on self care brands for consumer
Offering products like
Otrivin (nasal spray)
Voveran cream (analgesic cream)
BUSINESS SEGMENT
PRODUCTNAMES
THERAPEUTIC AREA
COMMENT MARKET SHARE
PHARMA VOVERAN PAIN ANDINFLAMMATOYR
RANK 1 11.4 %
OTRIVIN NASAL SPRAY
RANK 1 27.0 %
MACALVIT CALCIUMSUPPLIMENT
RANK 3 6.9 %
BUSINESS SEGMENT
BRANDS THERAPEUTIC AREA
COMMENTS MARKET SHARE
OTC TOTALSANDOZ BRAND
CALCIUM SUPLLEMENT
RANK 2 14.5%
GENERIC FORISTAL ANTI HISTAMINIC
RANK 1 30 %
Novartis india ltd has 4 manufacturing sites in india approved by
the EU and USFDA
Kolshet:- Houses the sandos devellopment center and Anti TB
formulation plant for global project.
Turbhe:-dedicated cephaloshporins manufacturing site for API &
FDF since 2001
Kalwe :- oral solid dosage plant with capacity of 1 billion unites ,
expansion to 5 billion unites under way
Mahad :- dedicated fermentation plant
Segmental performance
Pharmaceutical Business(contribution 66% )
Sales :- Rs 1552.4mn
Growth :- 13.1 %
OTC Business (Contribution 18% )
Sales :- Rs 422.1 mn
Growth :- 25.9 %
Generic Business ( Contribution 5.7 % )
Sales :- 135mn
Growth :- -4.2%
Animal health business (Contribution 10.2%)
Sales :- 238.8 mn
Growth :- -3.3%
Novartis operates in 140 countries
Company having strong distribution channel
of 20 c&f agents and approximately 250 stokist
in india.
To prevent counterfeiting,Novartis pays much
attention to the distribution process and
channels
•Research and development orientation
•Having research brand in each segmentVALUE
•Global presence in 140 countries
•ALCON surgical division for eye careRARE
•Brand image in all 3 prospects
•Brand as product attributes
•Brand image as organizational attributes
•Brand image as visual imagery
INIMITABLE
•The vision and mission clearly states there orientation towards research and development and bringing innovation to the product which are profitable and will help increase shareholders value
ORGANIZATIONAL SUPPORT/USAGE